A novel risk model of three gefitinib-related genes FBP1, SBK1 and AURKA is related to the immune microenvironment and is predicting prognosis of lung adenocarcinoma patients
Figure 8.The prognosis values and levels of the DEGTGs in LUAD. (A) Prognosis related genes; (B, C) The levels of DEGTGs in LUAD. Abbreviations: DEGTGs: differentially expressed Gefitinib target genes; LUAD: lung adenocarcinoma.